Tingzhuang Yi
Overview
Explore the profile of Tingzhuang Yi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang H, Fan T, Lu Y, Que L, Zou B, Huang L, et al.
Int J Cancer
. 2025 Feb;
PMID: 39902938
Hearing impairment is one of the most common chief complaints in newly diagnosed nasopharyngeal carcinoma (NPC) patients, but baseline audiometric assessments are seldom reported. This study aims to investigate the...
2.
Liao Y, Yi T, Tan K, Su X, Chen S, Lu M, et al.
Spectrochim Acta A Mol Biomol Spectrosc
. 2025 Jan;
330:125680.
PMID: 39746254
Hypochlorous acid (HClO) represents a typical endogenous reactive oxygen species primarily generated within mitochondria, with excessive levels intimately linked to numerous pathological conditions. Consequently, the detection of mitochondrial HClO in...
3.
Yi T, Wang C, Ye X, Lin J, Lin C, Lin C, et al.
Int J Surg
. 2024 Oct;
110(12):7701-7719.
PMID: 39434688
Background: N6-methyladenosine (m6A) modification plays a crucial role in the progression of various cancers, including pancreatic cancer, by regulating gene expression. However, the specific mechanisms by which m6A affects pancreatic...
4.
Huang J, Lin J, Zhong T, Qin Z, Li G, Yi T, et al.
Int J Biol Macromol
. 2024 Oct;
281(Pt 3):136538.
PMID: 39396585
To investigate the role of LINC00894 in oxaliplatin chemoresistance of hepatocellular carcinoma (HCC) and its mechanisms. The oxaliplatin-resistant HCC cell lines were established. IC50 of oxaliplatin was calculated by CCK-8...
5.
Sun X, Yang D, Li Y, Shi J, Zhang X, Yi T
Peptides
. 2024 Apr;
177:171203.
PMID: 38582303
This study assesses the efficacy of an innovative therapeutic approach that combines GLP-1 and amylin analogues for weight reduction. Focusing on GLP-1 analogues from bullfrog (Rana catesbeiana), we designed ten...
6.
Wu J, Yi T, Zhuo C, Wang D, Zhang M, Hu R, et al.
J Cell Physiol
. 2024 Feb;
239(5):e31220.
PMID: 38372068
Recent studies have indicated that dysregulation of the Hippo/Yes-associated protein (YAP) axis is associated with tumor progression and therapy resistance in various cancer types, including lung adenocarcinoma (LUAD). Understanding the...
7.
Long J, Qin F, Luo J, Zhong G, Huang S, Jing L, et al.
Bioorg Chem
. 2023 Dec;
143:107026.
PMID: 38103330
A series of novel hybrid compounds were designed, synthesized, and utilized as multi-target drugs to treat Alzheimer's disease (AD) by connecting capsaicin and tacrine moieties. The biological assays indicated that...
8.
Wang C, Yi T, Li X, Cui J, Li B, Qin Y, et al.
J Cell Mol Med
. 2023 Nov;
28(2):e18033.
PMID: 38009603
In our previous research, we proved that ailanthone (AIL) inhibits the growth of gastric cancer (GC) cells and causes apoptosis by inhibiting P23. However, we still find some GC organoids...
9.
Wu C, Liu X, Zhong L, Zhou Y, Long L, Yi T, et al.
Oxid Med Cell Longev
. 2023 Mar;
2023:9245667.
PMID: 36865349
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent hepatic pathology worldwide. However, the precise molecular mechanisms for NAFLD are still not sufficiently explained. Recently, a new mode of cell...
10.
Yi N, Zhao H, He J, Xie X, Liang L, Zuo G, et al.
Sci Rep
. 2023 Feb;
13(1):2345.
PMID: 36759514
Almost 50% of esophageal adenocarcinoma (EAC) patients progressed from Barrett's esophagus (BE). EAC is often diagnosed at late stages and is related to dismal prognosis. However, there are still no...